New p53-based anti-cancer therapeutic strategies
- PMID: 9951684
- DOI: 10.1007/BF02787204
New p53-based anti-cancer therapeutic strategies
Abstract
The p53 gene is frequently mutated in human tumours and therefore an important target for therapeutic intervention. Several p53-based strategies for treatment of cancer are currently under development. p53 gene therapy has resulted in tumour regression in patients with lung cancer. A mutant adenovirus can obliterate tumour cells carrying mutant p53 or lacking p53, but is unable to replicate in normal cells. Furthermore, current studies suggest that reactivation of mutant p53 proteins in tumours using small p53-activating molecules may initiate p53-dependent apoptosis and thus eliminate the tumour.
Similar articles
-
Targeting p53 in cancer.Curr Med Chem Anticancer Agents. 2001 Aug;1(2):151-61. doi: 10.2174/1568011013354741. Curr Med Chem Anticancer Agents. 2001. PMID: 12678764 Review.
-
Therapeutic exploitation of the p53 pathway.Trends Mol Med. 2002;8(4 Suppl):S38-42. doi: 10.1016/s1471-4914(02)02309-2. Trends Mol Med. 2002. PMID: 11927286 Review.
-
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.Drugs R D. 2007;8(3):176-87. doi: 10.2165/00126839-200708030-00005. Drugs R D. 2007. PMID: 17472413 Review.
-
Advances in adenovirus-mediated p53 cancer gene therapy.Expert Opin Biol Ther. 2013 Nov;13(11):1569-83. doi: 10.1517/14712598.2013.845662. Expert Opin Biol Ther. 2013. PMID: 24107178
-
INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.BioDrugs. 2003;17(3):216-22. doi: 10.2165/00063030-200317030-00010. BioDrugs. 2003. PMID: 12749760 Review.
Cited by
-
Carcinogenesis and cancer prevention: the process and the disease deserve a better understanding.J Carcinog. 2002 Nov 15;1(1):1. doi: 10.1186/1477-3163-1-1. J Carcinog. 2002. PMID: 12605711 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous